AAAAAA

   
Results: 1-8 |
Results: 8
Surprises of genetic engineering - A possible model of polyglucosan body disease
Authors: Raben, N Danon, M Lu, N Lee, E Shliselfeld, L Skurat, AV Roach, PJ Lawrence, JC Musumeci, O Shanske, S DiMauro, S Plotz, P
Citation: N. Raben et al., Surprises of genetic engineering - A possible model of polyglucosan body disease, NEUROLOGY, 56(12), 2001, pp. 1739-1745
Modulation of disease severity in mice with targeted disruption of the acid alpha-glucosidase gene
Authors: Raben, N Nagaraju, K Lee, E Plotz, P
Citation: N. Raben et al., Modulation of disease severity in mice with targeted disruption of the acid alpha-glucosidase gene, NEUROMUSC D, 10(4-5), 2000, pp. 283-291
Adeno-associated virus in normal and myositis human skeletal muscle
Authors: Tezak, Z Nagaraju, K Plotz, P Hoffman, EP
Citation: Z. Tezak et al., Adeno-associated virus in normal and myositis human skeletal muscle, NEUROLOGY, 55(12), 2000, pp. 1913-1917
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies
Authors: Nagaraju, K Raben, N Loeffler, L Parker, T Rochon, PJ Lee, E Danning, C Wada, R Thompson, C Bahtiyar, G Craft, J van Huijsduijnen, RH Plotz, P
Citation: K. Nagaraju et al., Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies, P NAS US, 97(16), 2000, pp. 9209-9214
The inhibition of apoptosis in myositis and in normal muscle cells
Authors: Nagaraju, K Casciola-Rosen, L Rosen, A Thompson, C Loeffler, L Parker, T Danning, C Rochon, PJ Gillespie, J Plotz, P
Citation: K. Nagaraju et al., The inhibition of apoptosis in myositis and in normal muscle cells, J IMMUNOL, 164(10), 2000, pp. 5459-5465
Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFRneg cell line
Authors: Martiniuk, F Chen, A Donnabella, V Arvanitopoulos, E Slonim, AE Raben, N Plotz, P Rom, WN
Citation: F. Martiniuk et al., Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFRneg cell line, BIOC BIOP R, 276(3), 2000, pp. 917-923
Quantitative assessment of myositis in thigh muscles using magnetic resonance imaging
Authors: Bartlett, ML Ginn, L Beitz, L Villalba, ML Plotz, P Bacharach, SL
Citation: Ml. Bartlett et al., Quantitative assessment of myositis in thigh muscles using magnetic resonance imaging, MAGN RES IM, 17(2), 1999, pp. 183-191
Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase
Authors: Amalfitano, A McVie-Wylie, AJ Hu, H Dawson, TL Raben, N Plotz, P Chen, YT
Citation: A. Amalfitano et al., Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase, P NAS US, 96(16), 1999, pp. 8861-8866
Risultati: 1-8 |